1.Gotlib J. World Health Organization-defned eosinophilic disorders: 2015 update on diagnosis, risk stratifcation, and management. Am J Hematol. 2015. 90:1077–89.
2.Ogata M., Ogata Y., Kohno K., Uno N., Ohno E., Ohtsuka E, et al. Eosinophilia associated with adult T-cell leukemia: role of interleukin 5 and granulocyte-macrophage colony-stimulating factor. Am J Hematol. 1998. 59:242–5.
Article
3.Montgomery ND., Dunphy CH., Mooberry M., Laramore A., Foster MC., Park SI, et al. Diagnostic complexities of eosinophilia. Arch Pathol Lab Med. 2013. 137:259–69.
Article
4.Bain BJ. Hypereosinophilia. Curr Opin Hematol. 2000. 7:21–5.
Article
5.Desenne JJ., Acquatella G., Stern R., Muller A., Sanchez M., Somoza R. Blood eosinophilia in Hodgkin's disease. A follow-up of 25 cases in Venezuela. Cancer. 1992. 69:1248–53.
Article
6.Utsunomiya A., Ishida T., Inagaki A., Ishii T., Yano H., Komastsu H, et al. Clinical signifcance of a blood eosinophilia in adult T-cell leukemia/lymphoma: a blood eosinophilia is a signifcant unfavorable prognostic factor. Leuk Res. 2007. 31:915–20.
7.McKelvie PA., Oon S., Romas E., Nandurkar H., Tam CS. A case of systemic anaplastic lymphoma kinase-negative anaplastic large cell lymphoma associated with hypereosinophilia, granulomatous myositis and vasculitis. Leuk Lymphoma. 2012. 53:2279–82.
Article
8.Orofno N., Guidotti F., Cattaneo D., Sciume M., Gianelli U., Cortelezzi A, et al. Marked eosinophilia as initial presentation of breast implant-associated anaplastic large cell lymphoma. Leuk Lymphoma. 2016. 57:2712–5.
9.Powers ML., Watson BW., Frater JL., Kreisel F., Hassan A. Peripheral eosinophilia camoufaging anaplastic large cell lymphoma. Int J Surg Pathol. 2011. 19:405–8.
10.Gonsalves WI., He R., Pardanani A., Gupta V., Smeltzer JP., Hanson CA, et al. Chronic eosinophilic leukemia-not otherwise specifed (NOS) in the background of a large cell lymphoma. Case Rep Hematol. 2013. 2013:458303.
11.Fan YS., Rizkalla K. Comprehensive cytogenetic analysis including multicolor spectral karyotyping and interphase fuorescence in situ hybridization in lymphoma diagnosis. a summary of 154 cases. Cancer Genet Cytogenet. 2003. 143:73–9.
12.Wan TS. Cancer cytogenetics: methodology revisited. Ann Lab Med. 2014. 34:413–25.
Article
13.Mereu E., Pellegrino E., Scarfo I., Inghirami G., Piva R. The heterogeneous landscape of ALK negative ALCL. Oncotarget. 2017. 8:18525–36.
Article
14.Mussolin L., Pillon M., Bonato P., Leszl A., Franceschetto G., Di Meglio A, et al. Cytogenetic analysis of pediatric anaplastic large cell lymphoma. Pediatr Blood Cancer. 2010. 55:446–51.
Article
15.Zeng Y., Feldman AL. Genetics of anaplastic large cell lymphoma. Leuk Lymphoma. 2016. 57:21–7.
Article